CLINICAL_TRIALS
research
· 2025-02-27
Clinical Trial Update: Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG [EARLY_Phase 1]
Summary
An early-phase (Phase 1) clinical trial is evaluating superselective intra-arterial cerebral infusion of temsirolimus for high-grade glioma, including glioblast…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nader Sanai | Conditions: High Grade Glioma, Glioma | EARLY_Phase 1 | Status: RECRUITING